Compass Therapeutics Inc. (CMPX)

AI Score

Unlock

2.13

0.06 (2.90%)

At close: Apr 24, 2025, 3:59 PM

2.19

2.82%

Pre-market: Apr 25, 2025, 06:53 AM EDT

Compass Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018
Revenue	n/a	850K	n/a	2.84M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	463K	468K	466K	475K	481K	484K	487K	498K	435K	396K	406K	409K	413K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	850K	-463K	2.38M	-466K	-475K	-481K	-484K	-487K	-498K	-435K	-396K	-406K	-409K	-413K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-12.24M	-15.04M	-12.77M	-15.39M	-11.93M	-13.34M	-9.71M	-12.89M	-12.6M	-8.99M	-7.18M	-13M	-5.85M	-55.69M	-7.34M	-7.95M	-8.96M	-5.07M	-5.83M	-6.4M	-8.38M	-8.67M	-10.59M	n/a	n/a	n/a
Interest Income	1.76M	1.97M	n/a	1.98M	1.96M	2.06M	n/a	1.29M	623K	424K	20K	4K	1K	9K	15K	18K	22K	7K	41K	96K	176K	237K	n/a	n/a	n/a	n/a
Pretax Income	-10.48M	-13.08M	-10.79M	-13.41M	-9.96M	-11.28M	-7.84M	-11.59M	-11.97M	-8.49M	-7.16M	-12.99M	-5.97M	-55.79M	-7.42M	-8.39M	-9.15M	-5.54M	-6.39M	-6.6M	-8.53M	-8.78M	-10.74M	n/a	n/a	21.00
Net Income	-10.48M	-13.08M	-10.79M	-13.41M	-9.96M	-11.28M	-5.96M	-10.3M	-11.35M	-8M	-7.14M	-12.98M	-5.97M	-55.8M	-7.42M	-8.39M	-9.15M	-5.56M	-6.4M	-6.61M	-8.55M	-8.81M	-10.77M	n/a	n/a	n/a
Selling & General & Admin	3.63M	4.72M	2.94M	2.66M	3.1M	3.11M	3.07M	2.96M	2.81M	3.13M	2.77M	3.43M	2.7M	2.17M	2.63M	3.54M	5.29M	2.08M	2.26M	3.1M	2.4M	3.28M	3.35M	n/a	n/a	n/a
Research & Development	8.61M	11.17M	9.37M	12.27M	8.83M	10.22M	6.64M	9.93M	9.79M	5.86M	4.42M	9.57M	3.15M	2.9M	4.7M	4.41M	3.67M	2.98M	3.57M	3.3M	5.98M	5.39M	7.24M	n/a	n/a	n/a
Other Expenses	n/a	n/a	1.98M	-1.87M	n/a	n/a	1.87M	n/a	n/a	n/a	n/a	50.62M	-44K	50.62M	n/a	-18.42M	-8.95M	n/a	-2.23M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.24M	15.89M	12.31M	14.93M	11.93M	13.34M	9.71M	12.89M	12.6M	8.99M	7.18M	13M	5.85M	5.07M	7.34M	7.95M	8.96M	5.07M	5.83M	6.4M	8.38M	8.67M	10.66M	n/a	n/a	n/a
Interest Expense	n/a	n/a	n/a	1.87M	n/a	n/a	n/a	1.29M	623K	424K	20K	39K	78K	111K	142K	178K	212K	242K	276K	284K	312K	314K	3.28K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-309K	-307K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.24M	15.89M	12.77M	15.39M	11.93M	13.34M	9.71M	12.89M	12.6M	8.99M	7.18M	13M	5.85M	5.07M	7.34M	7.95M	8.96M	5.07M	5.83M	6.4M	8.38M	8.67M	10.66M	n/a	n/a	n/a
Income Tax Expense	n/a	n/a	419.72K	1.87M	505.59K	352.92K	-1.87M	-1.29M	-623K	-493K	-20K	-13K	34K	13K	142K	178K	212K	16K	16K	10K	26K	26K	29K	n/a	n/a	21.00
Shares Outstanding (Basic)	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M	51.91M	51.31M	61.12M	61.12M	52.11M	52.11M	61.12M	52.11M	52.11M	5M	n/a	n/a	n/a
Shares Outstanding (Diluted)	137.59M	137.59M	136.61M	127.67M	127.42M	126.73M	126.38M	105.19M	101.01M	100.95M	100.86M	51.91M	61.69M	51.91M	51.31M	61.12M	61.12M	52.11M	52.11M	61.12M	52.11M	52.11M	5M	n/a	n/a	n/a
EPS (Basic)	-0.08	-0.1	-0.08	-0.11	-0.08	-0.09	-0.05	-0.1	-0.11	-0.08	-0.07	-0.25	-0.1	-1.07	-0.14	-0.14	-0.15	-0.11	-0.12	-0.11	-0.16	-0.17	-2.15	n/a	n/a	n/a
EPS (Diluted)	-0.08	-0.1	-0.08	-0.11	-0.08	-0.09	-0.05	-0.1	-0.11	-0.08	-0.07	-0.25	-0.1	-1.07	-0.14	-0.14	-0.15	-0.11	-0.12	-0.11	-0.16	-0.17	-2.15	n/a	n/a	n/a
EBITDA	-11.77M	-14.58M	-12.31M	-14.93M	-11.46M	-12.86M	-9.23M	-11.11M	-11.49M	-8.06M	-6.73M	-12.6M	-5.49M	-4.65M	-6.91M	-6.86M	-8.5M	-4.63M	-5.33M	-5.79M	-7.67M	-8.44M	-10.07M	n/a	n/a	n/a
EBIT	-12.24M	-15.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	465K	466K	463K	468K	466K	475K	481K	484K	487K	498K	435K	396K	406K	409K	413K	1.07M	435K	437K	463K	521K	539K	534K	526K	n/a	n/a	n/a